Spleens from the chitin-treated 66cl4 tumor-bearing mice showed a significant increase in CD4+ T-cell percentages compared to spleens from untreated and anti-PD-1-treated 66cl4 tumor-bearing mice (Additional file 15: Fig. S13F). The gene discussed is CD4; the disease is neoplasm.